20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Understanding the Synthesis of 1-(4-Methylphenyl)-4,4,4-trifluorobutane-1,3-dione

The successful synthesis of pharmaceutical intermediates is a complex endeavor, requiring precise chemical transformations and meticulous process control. 1-(4-Methylphenyl)-4,4,4-trifluorobutane-1,3-dione (CAS: 720-94-5), a vital precursor for Celecoxib, is synthesized through specific chemical reactions that leverage its unique structural features. Understanding these synthesis routes is crucial for manufacturers aiming for efficient production and high-quality output.

A common method for preparing beta-diketones involves the Claisen condensation or similar acylation reactions. For 1-(4-Methylphenyl)-4,4,4-trifluorobutane-1,3-dione, a typical synthesis might involve the reaction between a methylphenyl-containing ester or ketone and a trifluoroacetylating agent. For instance, the reaction of 4'-methylacetophenone with ethyl trifluoroacetate in the presence of a strong base, such as sodium hydride or potassium carbonate, can yield the desired product. This reaction typically proceeds in a suitable organic solvent, with careful control of temperature and reaction time to optimize yield and minimize side products.

Key considerations during synthesis include the choice of base and solvent, the stoichiometry of reactants, and the purification methods employed. The presence of the trifluoromethyl group can influence the reactivity of the adjacent carbonyl group, requiring specific conditions for efficient acylation. Post-reaction workup often involves neutralization, extraction, and crystallization or distillation to isolate the pure intermediate. As a manufacturer, optimizing these steps is vital for reducing production costs and ensuring the final product's purity, which directly impacts its suitability for pharmaceutical use.

For pharmaceutical companies looking to buy this intermediate, understanding its synthesis pathway highlights the importance of partnering with experienced manufacturers. Our expertise in chemical synthesis allows us to consistently produce high-purity 1-(4-Methylphenyl)-4,4,4-trifluorobutane-1,3-dione, ensuring a reliable supply chain for Celecoxib manufacturers. We continuously refine our processes to improve efficiency and sustainability, providing our clients with a high-quality, cost-effective intermediate.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Cost-Effective Sourcing of Celecoxib Intermediate from China

Next: The Growing Market for Pharmaceutical Intermediates in China

All Rights Reserved